NI-THE

NiThe is a South African biotechnology company focused on developing a novel drug delivery platform that utilizes nickel-based coordination chemistry. The company's technology leverages the unique properties of nickel to create stable, targeted therapeutic complexes, particularly for oncology and infectious disease applications. By binding active pharmaceutical ingredients to specific carriers, NiThe aims to improve the bioavailability and safety profiles of existing and new drugs. The company is currently advancing its lead candidates through pre-clinical development, targeting high-unmet-need areas in the global healthcare market.